Cargando…

Cervical cancer in women under 30 years of age in Norway: a population-based cohort study

BACKGROUND: We compared women with incident cervical cancer under the age of 30 with older women with regard to stage, morphology, screening history and cervical cancer mortality in a population-based cohort study. METHODS: We included data from the Cancer Registry of Norway. Incidence rates (per 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravdal, Brit Helene, Lönnberg, Stefan, Skare, Gry Baadstrand, Sulo, Gerhard, Bjørge, Tone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977265/
https://www.ncbi.nlm.nih.gov/pubmed/33736628
http://dx.doi.org/10.1186/s12905-021-01242-3
_version_ 1783667096756944896
author Gravdal, Brit Helene
Lönnberg, Stefan
Skare, Gry Baadstrand
Sulo, Gerhard
Bjørge, Tone
author_facet Gravdal, Brit Helene
Lönnberg, Stefan
Skare, Gry Baadstrand
Sulo, Gerhard
Bjørge, Tone
author_sort Gravdal, Brit Helene
collection PubMed
description BACKGROUND: We compared women with incident cervical cancer under the age of 30 with older women with regard to stage, morphology, screening history and cervical cancer mortality in a population-based cohort study. METHODS: We included data from the Cancer Registry of Norway. Incidence rates (per 100,000 women-years) were calculated and joinpoint regression was used to analyse trends. The Nelson-Aalen cumulative hazard function for risk of cervical cancer death during a 15-year follow-up was displayed. The hazard ratios (HRs) of cervical cancer mortality with 95% confidence intervals (CIs) were derived from Cox regression models. RESULTS: The incidence of cervical cancer in women under the age of 30 has almost tripled since the 1950s, with the steepest increase during 1955–80 (with an annual percentage change (APC) of 7.1% (95%CI 4.4–9.8)) and also an increase after 2004 (3.8% (95%CI -1.3–9.2)). Out of 21,160 women with cervical cancer (1953–2013), 5.3% were younger than 30 years. A lower proportion of younger women were diagnosed at more advanced stages and a slightly higher proportion were diagnosed with adenocarcinoma and adenosquamous carcinoma comparing women above 30 years. The cumulative risk of cervical cancer death was lower for patients under the age of 30. However, the difference between the age groups decreased over time. The overall adjusted HR of cervical cancer mortality was 0.69 (95% CI 0.58–0.82) in women diagnosed under the age of 30 compared to older women. CONCLUSION: There has been an increase in cervical cancer incidence in women under the age of 30. Cervical cancer in younger women was not more advanced at diagnosis compared to older women, and the cervical cancer mortality was lower. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-021-01242-3.
format Online
Article
Text
id pubmed-7977265
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79772652021-03-22 Cervical cancer in women under 30 years of age in Norway: a population-based cohort study Gravdal, Brit Helene Lönnberg, Stefan Skare, Gry Baadstrand Sulo, Gerhard Bjørge, Tone BMC Womens Health Research Article BACKGROUND: We compared women with incident cervical cancer under the age of 30 with older women with regard to stage, morphology, screening history and cervical cancer mortality in a population-based cohort study. METHODS: We included data from the Cancer Registry of Norway. Incidence rates (per 100,000 women-years) were calculated and joinpoint regression was used to analyse trends. The Nelson-Aalen cumulative hazard function for risk of cervical cancer death during a 15-year follow-up was displayed. The hazard ratios (HRs) of cervical cancer mortality with 95% confidence intervals (CIs) were derived from Cox regression models. RESULTS: The incidence of cervical cancer in women under the age of 30 has almost tripled since the 1950s, with the steepest increase during 1955–80 (with an annual percentage change (APC) of 7.1% (95%CI 4.4–9.8)) and also an increase after 2004 (3.8% (95%CI -1.3–9.2)). Out of 21,160 women with cervical cancer (1953–2013), 5.3% were younger than 30 years. A lower proportion of younger women were diagnosed at more advanced stages and a slightly higher proportion were diagnosed with adenocarcinoma and adenosquamous carcinoma comparing women above 30 years. The cumulative risk of cervical cancer death was lower for patients under the age of 30. However, the difference between the age groups decreased over time. The overall adjusted HR of cervical cancer mortality was 0.69 (95% CI 0.58–0.82) in women diagnosed under the age of 30 compared to older women. CONCLUSION: There has been an increase in cervical cancer incidence in women under the age of 30. Cervical cancer in younger women was not more advanced at diagnosis compared to older women, and the cervical cancer mortality was lower. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-021-01242-3. BioMed Central 2021-03-18 /pmc/articles/PMC7977265/ /pubmed/33736628 http://dx.doi.org/10.1186/s12905-021-01242-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Gravdal, Brit Helene
Lönnberg, Stefan
Skare, Gry Baadstrand
Sulo, Gerhard
Bjørge, Tone
Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title_full Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title_fullStr Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title_full_unstemmed Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title_short Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
title_sort cervical cancer in women under 30 years of age in norway: a population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977265/
https://www.ncbi.nlm.nih.gov/pubmed/33736628
http://dx.doi.org/10.1186/s12905-021-01242-3
work_keys_str_mv AT gravdalbrithelene cervicalcancerinwomenunder30yearsofageinnorwayapopulationbasedcohortstudy
AT lonnbergstefan cervicalcancerinwomenunder30yearsofageinnorwayapopulationbasedcohortstudy
AT skaregrybaadstrand cervicalcancerinwomenunder30yearsofageinnorwayapopulationbasedcohortstudy
AT sulogerhard cervicalcancerinwomenunder30yearsofageinnorwayapopulationbasedcohortstudy
AT bjørgetone cervicalcancerinwomenunder30yearsofageinnorwayapopulationbasedcohortstudy